Overview
Announcements

Ordinary Re-Weighting | DER AKTIONÄR BIOTECH SUPERTRENDS INDEX | Effective Date 3rd April 2024

DER AKTIONÄR BIOTECH SUPERTRENDS INDEX:

In the ordinary re-weighting, the following composition will be implemented effective open 3rd April 2024:

ARROWHEAD PHARMACEUTICALS INC
BIONTECH SE
BLUEPRINT MEDICINES CORP
CRISPR THERAPEUTICS AG
DENALI THERAPEUTICS INC
ECKERT & ZIEGLER STRAHLEN UND MEDIZINTECHNIK AG
ILLUMINA INC
IMMUNOCORE HOLDINGS PLC
INTUITIVE SURGICAL INC
MADRIGAL PHARMACEUTICALS INC
SWEDISH ORPHAN BIOVITRUM AB
VIKING THERAPEUTICS INC
VOYAGER THERAPEUTICS INC